Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes - Wikidata - thesis-toulmin - TriplyDB

Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes

Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes

http://www.wikidata.org/entity/Q24633568

about

Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases Update on the Management of Aspirin-Exacerbated Respiratory Disease Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances Lipid mediators and allergic diseases Eicosanoid Mediators in the Airway Inflammation of Asthmatic Patients: What is New?A Review of Classification Schemes for Chronic Rhinosinusitis with Nasal Polyposis Endotypes Platelets in patients with aspirin-exacerbated respiratory disease Biological effects of leukotriene E4 on eosinophils Cysteinyl leukotrienes and their receptors; emerging concepts Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99 A review on leukotrienes and their receptors with reference to asthma Aspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the future Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.Eosinophil production of prostaglandin D2 in patients with aspirin-exacerbated respiratory disease.Chronic Rhinosinusitis: More Than Just "Asthma of the Upper Airway"Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response Characterization of platelet-monocyte complexes in HIV-1-infected individuals: possible role in HIV-associated neuroinflammation.Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors.Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma Biology of nasal polyposis.Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation.The whole-genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge.P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma.PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation.Clustering drug-drug interaction networks with energy model layouts: community analysis and drug repurposing.Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.Exploration of the Sphingolipid Metabolite, Sphingosine-1-phosphate and Sphingosine, as Novel Biomarkers for Aspirin-exacerbated Respiratory Disease.Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity.Cysteinyl leukotriene receptors, old and new; implications for asthma.Immunopathogenesis of allergic disorders: current concepts.Pathogenesis of aspirin-exacerbated respiratory disease and reactions.Platelets and allergic inflammation.Aspirin-exacerbated respiratory disease: characteristics and management strategies.Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis.Is there a future for biologics in the management of chronic rhinosinusitis?Aspirin-exacerbated respiratory disease and current treatment modalities.

P2860

Q26739670-66BAA077-BF79-42CC-A75E-68185155A90C Q26749097-4D21E000-11E0-49E3-AF50-7BC4B0269310 Q26750424-3DFAB416-E617-4606-859F-9E6DEF5A390F Q27023936-E4724069-EEE6-465C-8EEE-C88A510F8714 Q28079269-3E0D23DA-0288-4362-8DDB-9249C2CB88BD Q28079332-7DBA9908-89C9-4B03-B995-09073B6C2712 Q28080840-E3FD4A0C-D261-4E2D-A27C-6DAD23C965E6 Q28238927-3EAF18C2-68E4-48A6-B1ED-358776251DE9 Q28243252-324EB18A-3EEB-4DAF-A79F-13373CD0A5CD Q28275552-7028A19E-AC9B-4C1F-A175-C3B2582A3139 Q28294597-0996A1C9-6AD0-484C-9C85-6CDA76A30BFE Q30238776-18DC8457-C446-46C5-B212-E68BB9B3A4C2 Q30275780-631AF505-493F-4E5E-BCE2-C36003A97AE9 Q30276354-A9B288C3-B671-4244-8F51-58A7C92D7C32 Q30278686-D35B7CD3-AFBC-4C68-B891-5EDD5BCA0AD8 Q30384450-24698A7E-2D89-499E-B499-411C87BDFA1C Q30829121-FFE1E585-4524-4955-9D26-CD6079AE8A2C Q33573879-44057922-CC73-4F26-B680-315DE7617865 Q33693274-432DFC1D-B3EC-4C74-BB60-491BB038ACB0 Q34473270-AF0E64B4-3918-430A-BC43-A23DD6329561 Q34986906-7B23DB54-7E47-4663-9A9D-B7090F4EB2F9 Q35576575-082F31C8-3D44-46EB-BEFE-E7B5C4A00141 Q36119388-D8E00041-79B5-4C98-A411-173691E04D45 Q36128536-C007E8A8-0A11-4B39-A492-955F0350FD74 Q36140425-CDDC46DA-7A54-458B-ABD3-4BA77AA7D063 Q36357862-D2FD2AC5-6A16-48D5-9285-AA8F488D0B08 Q36504328-E82139FC-36D9-4FD0-BD5D-F4E9F0E026B5 Q37098084-067CCE38-1ADD-46F3-A8D5-FACEC755F3F3 Q37236776-657E0CAD-6A12-4821-B984-FF8D13175130 Q37240446-C49B0F47-BE34-4233-9DEE-DAC14D1A10CA Q37405580-07AFA295-51BA-4928-8907-7906FC562093 Q37406340-9F37BACE-F510-46FC-8D6F-691168D352C5 Q38038319-02B20C2F-B53E-4501-8054-1A5120BC3D35 Q38085051-972D116E-647C-4330-B855-C6A189DE1EEA Q38103710-1396705D-EAA9-45C1-B23D-1D7DECCDC492 Q38202705-9D640ADF-DD9D-4079-B3B6-B7E592433E0A Q38455960-9959AF23-580F-4C20-844B-8A723CD3741B Q38609538-699400B4-DED4-48EB-BDA7-796832187EB0 Q38814643-A1C203F1-2D76-4123-B9FA-28FD4396D728 Q38931124-A8EDA689-163A-4BCF-889D-40ABC7769A1B

P2860

Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes

http://www.wikidata.org/entity/Q24633568

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@ast

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@en

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@nl

type

label

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@ast

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@en

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@nl

prefLabel

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@ast

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@en

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@nl

P1433

Q24633568-3D3742F5-F038-45DE-BF4A-4752ECF88110

P1476

Q24633568-1924A887-AF2A-4EE6-A9CA-24D5D8AA89DF

P2093

Q24633568-26758C2A-9D33-474E-AB49-2B77063B15F2

Q24633568-2BF807B8-EBF4-47FD-A6C6-A4F4D81DC68B

Q24633568-80D8CC39-6D65-4CFD-95A2-9ADED009B968

Q24633568-82C38C99-B141-43EE-B997-AE4E0D6FF6B8

Q24633568-85486997-A779-4EE9-8C97-56BA3B681A74

Q24633568-E282DF75-F64A-4D91-9319-C620EB4EC5F1

Q24633568-E46C22D5-83BB-4E43-8A0E-0ACDAF294E61

Q24633568-E86452D1-FECD-4B77-BDE0-DA553AC10EF6

P2860

Q24633568-01A52520-C9A4-4BBD-8BFD-0350B6F98FB9

Q24633568-1585053E-79C1-4000-87C6-AE7B33697A7D

Q24633568-15E0282A-12A2-4ECE-8022-687147D17CAF

Q24633568-27681F5E-AE2F-4526-B65E-33414DA9F40E

Q24633568-2DC20A2E-C674-4090-9360-D70F12BEF320

Q24633568-3E9BC7EB-0C73-412D-A301-B62F0D4BF752

Q24633568-47293EF4-6006-45B2-BE63-8F029D96E15F

Q24633568-4EC08FBB-64D6-4DA3-AD63-FD87F26C5AD6

Q24633568-5E11E90A-D446-40F0-B5E5-8C9C9FC526BE

Q24633568-5E6CD86A-4B66-4423-9F94-FD2FB714304C

P304

Q24633568-C2A37E50-78AA-4775-BDA5-130A9E53C9F6

P31

Q24633568-A01F8AAB-47BC-4B92-B744-D9F7DCEAD324

P3181

Q24633568-5400367B-95DB-416A-9A26-D3A109B24294

P356

Q24633568-C705F11E-900F-42F6-90B1-C856366CE1DE

P407

Q24633568-48FF1A37-688D-4F91-8F27-AA21BE233F13

P433

Q24633568-1D209F70-1A71-438E-856F-69DAA822D0F1

P478

Q24633568-44624874-1883-49B6-AA14-BA44869749EF

P50

Q24633568-A82A33E8-322A-41FC-8664-71576AF12AA2

P577

Q24633568-44D5791B-34D3-41C3-B6D2-63847C5C83DA

P5875

Q24633568-BABDF217-446F-4E54-9B49-C02AAC0C6453

P698

Q24633568-86C76AAB-C23D-43D0-9C54-C86130EE0F49

P921

Q24633568-B2BF06B7-8167-4846-A9BD-A215699409DB

Q24633568-DB61DE9A-640C-4963-BC2A-00012092ABBD

P932

Q24633568-E7CAE81F-18C8-438E-A44E-3229B538CBAE

P3181

P356

BLOOD-2011-10-384826

P1433

P1476

Cysteinyl leukotriene overprod ...... y platelet-adherent leukocytes

@en

P2093

Heng Chhay

http://www.w3.org/2001/XMLSchema#string

Joshua A Boyce

http://www.w3.org/2001/XMLSchema#string

Mariana C Castells

http://www.w3.org/2001/XMLSchema#string

Molly S Kidder

http://www.w3.org/2001/XMLSchema#string

Neil Bhattacharyya

http://www.w3.org/2001/XMLSchema#string

Shiliang Shen

http://www.w3.org/2001/XMLSchema#string

Tanya M Laidlaw

http://www.w3.org/2001/XMLSchema#string

Wei Xing

http://www.w3.org/2001/XMLSchema#string

P2860

Purification of human lung leukotriene C4 synthase and preparation of a polyclonal antibody

Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4

Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma

Platelets amplify inflammation in arthritis via collagen-dependent microparticle production

Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland

Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease

Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma

Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge

Transcellular lipoxygenase metabolism between monocytes and platelets

P304

3790-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

287913

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2011-10-384826

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Ginger Lohr Milne

P577

2012-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221764279

http://www.w3.org/2001/XMLSchema#string

P698

22262771

http://www.w3.org/2001/XMLSchema#string

P921

P932

3335383

http://www.w3.org/2001/XMLSchema#string